Eli Lilly announced impressive Q1 2024 financial results, with revenue surging by 26% YoY and exceeding expectations for earnings per share. The company raised its full-year 2024 revenue guidance ...
Glencar has taken over the construction of a life sciences building near Cambridge from collapsed contractor Readie. Readie ...
20-year-old charged for allegedly jumping 78-year-old man with dementia, police say Olive oil may lower your risk of dementia ...
Eli Lilly will invest an additional $5.3 billion into a new manufacturing site, boosting production for its weight loss and diabetes medications Mounjaro and Zepbound, the pharmaceutical firm said ...
Eli Lilly sells two of the most sought-after treatments -- those prescribed for weight management. Mounjaro and Zepbound are driving double-digit earnings growth at the big pharma company.
Governor J. B. Pritzker has officially signed the budget for the 2025 fiscal year. Jake Mintz and Jordan Shusterman discuss ...
The anti-obesity drug market will be worth $130 billion by 2030, Goldman Sachs said. New products such as Eli Lilly's Zepbound prompted the bank to raise its forecast. The FDA approved the pharma ...
The incident comes after a series of official investigations last year related to the issuance of fake birth certificates at a time when China is trying to boost its birth rate. Cardinal now expects ...
Whether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But for income investors, generating consistent cash flow from ...